These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 21919910

  • 1. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP.
    Raoult E, Roussel BD, Bénard M, Lefebvre T, Ravni A, Ali C, Vivien D, Komuro H, Fournier A, Vaudry H, Vaudry D, Galas L.
    J Neurochem; 2011 Dec; 119(5):920-31. PubMed ID: 21919910
    [Abstract] [Full Text] [Related]

  • 2. The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32.
    Vaudry D, Gonzalez BJ, Basille M, Pamantung TF, Fontaine M, Fournier A, Vaudry H.
    Proc Natl Acad Sci U S A; 2000 Nov 21; 97(24):13390-5. PubMed ID: 11087878
    [Abstract] [Full Text] [Related]

  • 3. Cortical-layer-specific effects of PACAP and tPA on interneuron migration during post-natal development of the cerebellum.
    Raoult E, Bénard M, Komuro H, Lebon A, Vivien D, Fournier A, Vaudry H, Vaudry D, Galas L.
    J Neurochem; 2014 Jul 21; 130(2):241-54. PubMed ID: 24646324
    [Abstract] [Full Text] [Related]

  • 4. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
    Aubert N, Falluel-Morel A, Vaudry D, Xifro X, Rodriguez-Alvarez J, Fisch C, de Jouffrey S, Lebigot JF, Fournier A, Vaudry H, Gonzalez BJ.
    J Neurochem; 2006 Nov 21; 99(4):1237-50. PubMed ID: 17026529
    [Abstract] [Full Text] [Related]

  • 5. Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells.
    Falluel-Morel A, Aubert N, Vaudry D, Basille M, Fontaine M, Fournier A, Vaudry H, Gonzalez BJ.
    J Neurochem; 2004 Dec 21; 91(5):1231-43. PubMed ID: 15569266
    [Abstract] [Full Text] [Related]

  • 6. Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells.
    Vaudry D, Falluel-Morel A, Basille M, Pamantung TF, Fontaine M, Fournier A, Vaudry H, Gonzalez BJ.
    J Neurosci Res; 2003 May 01; 72(3):303-16. PubMed ID: 12692897
    [Abstract] [Full Text] [Related]

  • 7. Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway.
    Vaudry D, Gonzalez BJ, Basille M, Anouar Y, Fournier A, Vaudry H.
    Neuroscience; 1998 Jun 01; 84(3):801-12. PubMed ID: 9579785
    [Abstract] [Full Text] [Related]

  • 8. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
    Cavallaro S, Copani A, D'Agata V, Musco S, Petralia S, Ventra C, Stivala F, Travali S, Canonico PL.
    Mol Pharmacol; 1996 Jul 01; 50(1):60-6. PubMed ID: 8700120
    [Abstract] [Full Text] [Related]

  • 9. Survival-promoting activity of pituitary adenylate cyclase-activating polypeptide in the presence of phosphodiesterase inhibitors on rat motoneurons in culture: cAMP-protein kinase A-mediated survival.
    Tomimatsu N, Arakawa Y.
    J Neurochem; 2008 Nov 01; 107(3):628-35. PubMed ID: 18717811
    [Abstract] [Full Text] [Related]

  • 10. Pituitary adenylate cyclase-activating polypeptide protects astroglial cells against oxidative stress-induced apoptosis.
    Masmoudi-Kouki O, Douiri S, Hamdi Y, Kaddour H, Bahdoudi S, Vaudry D, Basille M, Leprince J, Fournier A, Vaudry H, Tonon MC, Amri M.
    J Neurochem; 2011 May 01; 117(3):403-11. PubMed ID: 21244427
    [Abstract] [Full Text] [Related]

  • 11. The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells.
    Falluel-Morel A, Chafai M, Vaudry D, Basille M, Cazillis M, Aubert N, Louiset E, de Jouffrey S, Le Bigot JF, Fournier A, Gressens P, Rostène W, Vaudry H, Gonzalez BJ.
    J Neuroendocrinol; 2007 May 01; 19(5):321-7. PubMed ID: 17425606
    [Abstract] [Full Text] [Related]

  • 12. Localization of tissue plasminogen activator mRNA in the developing rat cerebellum and effects of inhibiting tissue plasminogen activator on granule cell migration.
    Ware JH, DiBenedetto AJ, Pittman RN.
    J Neurobiol; 1995 Sep 01; 28(1):9-22. PubMed ID: 8586968
    [Abstract] [Full Text] [Related]

  • 13. Pituitary adenylate cyclase-activating polypeptide (PACAP) is an upstream regulator of prodynorphin mRNA expression in neurons.
    Dong YX, Fukuchi M, Inoue M, Takasaki I, Tabuchi A, Wu CF, Tsuda M.
    Neurosci Lett; 2010 Nov 05; 484(3):174-7. PubMed ID: 20728507
    [Abstract] [Full Text] [Related]

  • 14. Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys.
    Aubert N, Basille M, Falluel-Morel A, Vaudry D, Bucharles C, Jolivel V, Fisch C, De Jouffrey S, Le Bigot JF, Fournier A, Vaudry H, Gonzalez BJ.
    J Comp Neurol; 2007 Oct 01; 504(4):427-39. PubMed ID: 17663433
    [Abstract] [Full Text] [Related]

  • 15. Pituitary adenylate cyclase-activating polypeptide inhibits caspase-3 activity but does not protect cerebellar granule neurons against beta-amyloid (25-35)-induced apoptosis.
    Vaudry D, Cottet-Rousselle C, Basille M, Falluel-Morel A, Fournier A, Vaudry H, Gonzalez BJ.
    Regul Pept; 2004 Dec 15; 123(1-3):43-9. PubMed ID: 15518892
    [Abstract] [Full Text] [Related]

  • 16. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L, Bizet P, Boutelet I, Gourcerol G, Fournier A, Vaudry H, Jégou S.
    Neuroscience; 2006 Nov 17; 143(1):155-63. PubMed ID: 16962718
    [Abstract] [Full Text] [Related]

  • 17. Non-proteolytic neurotrophic effects of tissue plasminogen activator on cultured mouse cerebrocortical neurons.
    Lee HY, Hwang IY, Im H, Koh JY, Kim YH.
    J Neurochem; 2007 Jun 17; 101(5):1236-47. PubMed ID: 17498240
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotective action of endogenous PACAP in cultured rat cortical neurons.
    Shintani N, Suetake S, Hashimoto H, Koga K, Kasai A, Kawaguchi C, Morita Y, Hirose M, Sakai Y, Tomimoto S, Matsuda T, Baba A.
    Regul Pept; 2005 Mar 15; 126(1-2):123-8. PubMed ID: 15620425
    [Abstract] [Full Text] [Related]

  • 19. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes.
    Shieh PC, Tsao CW, Li JS, Wu HT, Wen YJ, Kou DH, Cheng JT.
    Neurosci Lett; 2008 Mar 21; 434(1):1-5. PubMed ID: 18313848
    [Abstract] [Full Text] [Related]

  • 20. Involvement of stathmin 1 in the neurotrophic effects of PACAP in PC12 cells.
    Dejda A, Chan P, Seaborn T, Coquet L, Jouenne T, Fournier A, Vaudry H, Vaudry D.
    J Neurochem; 2010 Sep 01; 114(5):1498-510. PubMed ID: 20569302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.